Last reviewed: June 18, 2026

Last updated: June 18, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide weight loss therapy follows a structured weekly injection schedule designed to minimize side effects while achieving consistent metabolic benefits. The standard protocol begins at 0.25 milligrams per week and progresses through four dose escalations over four months. Understanding this timeline helps patients set realistic expectations and maintain consistency with their treatment plan.

Standard Semaglutide Weekly Injection Protocol

Semaglutide weight loss treatment uses a fixed weekly injection schedule rather than daily dosing, making it practical for long-term adherence. Patients inject once per week on the same day, typically subcutaneously in the abdomen, thigh, or upper arm. This consistent seven-day interval allows the medication to build up in your system gradually, establishing steady-state levels that support appetite reduction and improved metabolic control.

The typical dose progression moves from 0.25mg in week one, increases to 0.5mg by week five, then 1.0mg by week nine, 1.5mg by week thirteen, and finally reaches the standard maintenance dose of 2.4mg by week sixteen. This gradual escalation gives your body time to adapt to the medication, reducing nausea and gastrointestinal side effects that occur more frequently with rapid dose jumps. Some patients experience sufficient weight loss results at intermediate doses like 1.0mg or 1.5mg and maintain those levels long-term rather than advancing to the maximum dose.

How Dose Increases Work During Your Treatment

Each dose step occurs weekly, with most patients advancing to the next level unless side effects become intolerable or clinical response warrants holding at a current dose. Your healthcare provider evaluates how you tolerate each dose level before recommending progression, considering factors like nausea severity, appetite suppression effectiveness, and individual gastrointestinal response. If you experience significant side effects, staying at a lower dose for additional weeks allows your body to adjust before moving forward.

The 16-week titration schedule is not rigid—some clinical protocols extend this timeline to eight weeks per dose level for patients with prior gastrointestinal sensitivity or those seeking more gradual adjustment. Importantly, PlexusDx maintains one flat monthly price regardless of your current dose level, so your investment remains consistent whether you begin at 0.25mg or reach 2.4mg maintenance. This pricing structure removes the financial barrier to optimal dosing, letting your treatment focus on clinical benefit rather than cost considerations.

Maintenance Dosing and Long-Term Weight Loss Management

Once you reach 2.4mg weekly, this dose typically continues indefinitely for chronic weight management, as semaglutide requires ongoing use to sustain weight loss benefits. Studies show that patients who maintain consistent weekly injections experience continued appetite suppression and metabolic support month after month. If you discontinue treatment, appetite and eating patterns typically return within weeks, making the weekly injection protocol a long-term commitment rather than a short-term intervention.

Some patients find that their target weight loss occurs before reaching the maximum dose, allowing them to stabilize at 1.0mg, 1.5mg, or 2.0mg weekly. Your prescribing clinician can help you determine the lowest effective dose that delivers your desired results, potentially reducing side effects while maintaining weight loss. PlexusDx supports this individualized approach through its Precision Peptide Genetic Test, which identifies your genetic predispositions in GLP-1 receptor sensitivity and related metabolic pathways to guide optimal dosing strategies.

Comparing Weekly Semaglutide Injections to Other GLP-1 Formats

Semaglutide injections deliver the medication directly into subcutaneous tissue, where it absorbs steadily over seven days—this differs from oral semaglutide tablets, which rely on your digestive system and generally produce lower blood levels. The injection format also offers more reliable dose precision, eliminating variables like food interaction and absorption inconsistency that affect oral medications. For most patients seeking maximum efficacy and clinical predictability, the weekly injection remains the gold-standard delivery method.

PlexusDx compounds semaglutide injections in licensed 503A pharmacies, allowing customized strengths that match your exact dose escalation schedule without medication waste. Patients also have the option to choose oral semaglutide if they prefer tablet-based dosing, though this typically requires higher monthly pricing and more frequent dosing intervals. Your choice between injection and oral formats should align with your personal preference, lifestyle, and clinical goals—PlexusDx supports both pathways with transparent, dose-agnostic pricing.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

When should I take my weekly semaglutide injection?

Choose the same day each week—for example, every Monday morning—and maintain that consistent schedule for optimal medication levels. You can inject at any time of day, but consistency matters more than timing. Most patients find that keeping their injection day visible on a calendar or setting a phone reminder prevents missed doses that could disrupt weight loss progress.

What happens if I miss a semaglutide injection or take it late?

If you miss your injection, take it as soon as you remember unless your next scheduled dose is within two days. In that case, skip the missed dose and resume your normal schedule the following week to avoid doubling up. Missing one dose typically causes temporary appetite return but won't derail long-term results; simply resume your regular protocol and notify your PlexusDx provider if this becomes a pattern.

Does my PlexusDx price increase when my semaglutide dose goes up?

No—PlexusDx compounded semaglutide injections start at $149 per month flat, maintaining that price whether you're at 0.25mg or 2.4mg. Your dose may need to go up; your price won't. This structure removes cost barriers to finding your optimal therapeutic dose.

Can I stay on a lower semaglutide dose if it's working for my weight loss?

Yes, many patients achieve their target weight at doses like 1.0mg or 1.5mg and remain there long-term rather than advancing to 2.4mg. Your prescriber can help you determine the minimum effective dose that delivers your desired results while potentially reducing side effects. PlexusDx supports individualized dosing through clinical consultation and genetic testing insights.

How does PlexusDx Precision Peptide Genetic Testing help with semaglutide dosing?

The Precision Peptide Genetic Test identifies your genetic variants in GLP-1 receptor pathways (GLP1R rs6923761) and related metabolic genes like FTO and MC4R, revealing your baseline peptide sensitivity and predisposition to weight loss response. These insights help your clinician anticipate whether you'll respond optimally at standard doses or may benefit from adjusted protocols. This $99 add-on test, available after your first month of treatment, maps 14 pathways and 150+ genetic insights to personalize your weight loss strategy.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves